Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Return on Sales (2016 - 2025)

Utah Medical Products has reported Return on Sales over the past 16 years, most recently at 1.02% for Q4 2025.

  • Quarterly results put Return on Sales at 1.02% for Q4 2025, down 96.0% from a year ago — trailing twelve months through Dec 2025 was 0.01% (down 27.0% YoY), and the annual figure for FY2025 was 0.01%, down 27.0%.
  • Return on Sales for Q4 2025 was 1.02% at Utah Medical Products, down from 0.27% in the prior quarter.
  • Over the last five years, Return on Sales for UTMD hit a ceiling of 0.36% in Q3 2024 and a floor of 1.02% in Q4 2025.
  • Median Return on Sales over the past 5 years was 0.31% (2025), compared with a mean of 0.13%.
  • Biggest five-year swings in Return on Sales: surged 54bps in 2024 and later tumbled -96bps in 2025.
  • Utah Medical Products' Return on Sales stood at 0.2% in 2021, then tumbled by -31bps to 0.27% in 2022, then crashed by -128bps to 0.61% in 2023, then surged by 89bps to 0.06% in 2024, then crashed by -1474bps to 1.02% in 2025.
  • The last three reported values for Return on Sales were 1.02% (Q4 2025), 0.27% (Q3 2025), and 0.31% (Q2 2025) per Business Quant data.